App-Quantinova.ai

Role of Paroxysmal Nocturnal Hemoglobinuria (PNH) Clones in Refractory Anemias

Cecil Ross - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Cyclosporine eent

Selective Splenic Artery Embolization for the Treatment of Thrombocytopenia and Hypersplenism in Paroxysmal Nocturnal Hemoglobinuria (PNH)

Karen Brown - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

Eculizumab

Polymorphisms in VKORC1, CYP2C9, and CYP4F2 and Warfarin Dose in the Pediatric Population

Gregory D. Ayers - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Warfarin

Appropriateness and Timeliness of Initial Thromboprophylaxis in Patients with a Hospital Acquired Venous Thrombosis in a Single Center: A Case Control Study

Josephine Dela Cruz - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Prophylactic Use of Enoxaparin in Morbidly Obese Adolescents During Bariatric Surgery

Janelle D Vaughns - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Enoxaparin

Practical Experience of Thromboprophylaxis After Lower Limb Replacement Rivaroxaban Versus Enoxaparin

Kyoung Ha Kim - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

rivaroxaban

A Software for the Prescription of Prophylactic Treatment of Venous Thromboembolism (VTE) in Hospitalized Patients. Evaluation of the Prescriptive Mode

Laura Contino - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

N/A

The Incidence of Heparin-Induced Thrombocytopenia (HIT) After Prophylactic Heparin Exposure in Pediatric Intensive Care and Congenital Cardiology Patients: A Single Center, Prospective and Phase-IV Study: Turkish Experience

Gabil Mursalov - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Heparin

Safety and Long-Term Effects of Splenectomy At the Age of Two for Acute Splenic Sequestration in Sickle Cell Disease: A Retrospective Review

Yves Pastore - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

Hydroxyurea

Etiology and Management of Splenic Infarction and Splenic Vein Thrombosis: Unusual Causes of Abdominal Pain in Sickle Cell Trait Patient

Shuang Fu - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Warfarin

Cerebral Venous Thrombosis in Adolescents and Young Adults with Classical Hodgkin Lymphoma

Rebekah Ahmed - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Cyclophosphamide

Implication of Tissue Factor Bearing Microvesicles in Hypercoagulable State in Acute Promyelocytic Leukemia

Francois Mullier - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Phosphatidylserine

International Clinical Practice Guidelines for the Treatment and Prophylaxis of Thrombosis Associated with Central Venous Catheters in Patients with Cancer

Farge Dominique - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

From Phenomenology to Mechanism: Resistance to Annexin A5 Anticoagulant Activity Identifies a Subset of Patients with Antiphospholipid Antibodies and Thrombosis

Xiao Xuan Wu - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Phosphatidylserine

Development of Coagulation Factor Probes for the Identification of Procoagulant Circulating Tumor Cells

Garth W. Tormoen - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Fibrin Generation in Heparin-Induced Thrombocytopenia (HIT): Pathomechanistic Background for Novel Therapy and Prophylaxis

Hyun Sook Ahn - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Fibrinogen (IV)

Variability in Exposure of Epitope G40-R43 of Domain I in Commercial Anti-?2-Glycoprotein I IgG Elisas Influences the Diagnosis of the Antiphospholipid Syndrome

Hilde Kelchtermans - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Ectopic Expression of ADAMTS13 in Platelets As a Novel Therapeutic Approach for Arterial Thrombosis

Sheng-Yu Jin - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Fluorescein sodium

The Interaction of Coagulation Factor XI with Polyphosphate

Ingrid M. Verhamme - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Dextran sulfate

A Sensitized Whole Genome ENU Mutagenesis Screen Identifies an Arp2 Missense Mutation As a Novel Suppressor of Lethal Thrombosis in the Factor V Leiden Mouse

Guojing Zhu - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Hemostatic Solution

Filters

7277 Abstracts